Back to company

LICA PHARMACEUTICALS ApS: Financial statements 2021

CVR: 25332520

LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 370,721 and a net result of DKK 2,563,807 compared with DKK 843,617 the year before. That is an increase of 13.6% compared with the year before. Equity amounted to DKK 22,157,478. The solvency ratio was 99.4%. The company had 1 employee in the financial year.

Gross Profit
370,721 kr.
Profit/Loss
2,563,807 kr.
Equity
22,157,478 kr.
Total Assets
22,299,540 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-371 t.2.6 mio.22.2 mio.1
2020-326 t.844 t.19.6 mio.0
2019-280 t.2.8 mio.18.8 mio.-
2018-973 t.5.6 mio.18.4 mio.-
2017-409 t.812 t.12.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like LICA PHARMACEUTICALS ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

LICA PHARMACEUTICALS ApS: The 2020 annual report is outJun 21, 2021

LICA PHARMACEUTICALS ApS has published its annual report for 2020. Gross profit came to DKK 326,213, and the net result was DKK 843,617.

About LICA PHARMACEUTICALS ApS

LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.